Scotland has become the first part of the UK to approve a controversial gay lifestyle drug. This week, the Scottish Medicines Consortium approved the routine use of pre-exposure prophylaxis (PrEP), a drug mainly intended for men who do not have HIV but are at risk of contracting it through homosexual activity. The drug, which costs around £450 per patient, per month,

has been criticized for condoning promiscuous behavior. At the end of last year, NHS England also approved a “large scale clinical trial” of the drug, at a cost of up to £10 million. At the time, health and patient groups condemned the move as it emerged that funding for three vital treatments was blocked around the same time the trial was given the green light. READ MORE